Last reviewed · How we verify
Tranexamic Acid Dosage 2
Tranexamic Acid Dosage 2 is a Small molecule drug developed by Chinese Academy of Medical Sciences, Fuwai Hospital. It is currently FDA-approved. Also known as: Cyklokapron, Transamin.
Tranexamic acid is a small molecule inhibitor of plasminogen, used to treat conditions such as blood loss, surgical complications, COVID-19, and COVID-19 pneumonia. The typical dosage of tranexamic acid may vary depending on the specific condition being treated, but it has been studied in clinical trials for its efficacy in these areas.
At a glance
| Generic name | Tranexamic Acid Dosage 2 |
|---|---|
| Also known as | Cyklokapron, Transamin |
| Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures (NA)
- Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children (PHASE3)
- Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty (PHASE4)
- Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery (EARLY_PHASE1)
- Dose-Dependent Effects of Intraoperative Tranexamic Acid on Surgical Bleeding and Transfusion Requirements in Multilevel Thoracolumbar Spinal Surgery (NA)
- Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study (PHASE3)
- A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tranexamic Acid Dosage 2 CI brief — competitive landscape report
- Tranexamic Acid Dosage 2 updates RSS · CI watch RSS
- Chinese Academy of Medical Sciences, Fuwai Hospital portfolio CI
Frequently asked questions about Tranexamic Acid Dosage 2
What is Tranexamic Acid Dosage 2?
Who makes Tranexamic Acid Dosage 2?
Is Tranexamic Acid Dosage 2 also known as anything else?
What development phase is Tranexamic Acid Dosage 2 in?
Related
- Manufacturer: Chinese Academy of Medical Sciences, Fuwai Hospital — full pipeline
- Also known as: Cyklokapron, Transamin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing